BCOR and retinoblastoma: Recurrent inactivating somatic BCOR mutations have been identified in various hematological malignancies, acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia, medulloblastoma, and retinoblastoma [28, 29].